Search Results - "Balachandran, Harikrishnan"
-
1
NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage
Published in PLoS pathogens (12-08-2024)“…Natural killer (NK) cells play a critical role in virus control. However, it has remained largely unclear whether NK cell mobilization in SARS-CoV-2 infections…”
Get full text
Journal Article -
2
Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections
Published in Virology (New York, N.Y.) (01-12-2016)“…Abstract For studies on vaccines and therapies for HIV disease, SIV-HIV chimeric viruses harboring the HIV-1 env gene (SHIVenv) remain the best virus in…”
Get full text
Journal Article -
3
Recombinant Mycobacterium bovis BCG Prime-Recombinant Adenovirus Boost Vaccination in Rhesus Monkeys Elicits Robust Polyfunctional Simian Immunodeficiency Virus-Specific T-Cell Responses
Published in Journal of Virology (01-06-2009)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
4
Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib
Published in Leukemia & lymphoma (01-12-2009)“…Dasatinib, a dual Src/Abl tyrosine kinase inhibitor, has significant antileukemic effects against various imatinib mesylate-resistant BCR/ABL mutants. Despite…”
Get full text
Journal Article -
5
Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques
Published in Clinical and vaccine immunology (01-10-2014)“…Live attenuated nonpathogenic Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediates long-lasting immune responses, has been safely administered as a…”
Get full text
Journal Article -
6
Vaccination Reduces Simian-Human Immunodeficiency Virus Sequence Reversion through Enhanced Viral Control
Published in Journal of Virology (01-12-2010)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
7
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
Published in Immunity (Cambridge, Mass.) (14-12-2021)“…Viral mutations are an emerging concern in reducing SARS-CoV-2 vaccination efficacy. Second-generation vaccines will need to elicit neutralizing antibodies…”
Get full text
Journal Article -
8
FcαRI (CD89) is upregulated on subsets of mucosal and circulating NK cells and regulates IgA-class specific signaling and functions
Published in Mucosal immunology (01-08-2024)“…Immunoglobulin A (IgA) is the predominant mucosal antibody class with both anti- and pro-inflammatory roles1–3. However, the specific role of the IgA receptor…”
Get full text
Journal Article -
9
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Published in Nature communications (08-02-2023)“…Emerging variants of concern (VOCs) are threatening to limit the effectiveness of SARS-CoV-2 monoclonal antibodies and vaccines currently used in clinical…”
Get full text
Journal Article -
10
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses
Published in Cell reports (Cambridge) (08-02-2022)“…Understanding the long-term maintenance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity is critical for predicting protection against…”
Get full text
Journal Article -
11
Mosaic vaccines elicit CD8 + T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
Published in Nature medicine (01-03-2010)“…An effective HIV vaccine must elicit immune responses that recognize genetically diverse viruses. It must generate CD8+ T lymphocytes that control HIV…”
Get full text
Journal Article -
12
High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019
Published in Immunology and cell biology (01-02-2023)“…The long‐term health consequences of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection are still being understood. The molecular and…”
Get full text
Journal Article -
13
Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques
Published in Molecular therapy (01-11-2016)“…The design of an effective HIV-1 vaccine remains a major challenge. Several vaccine strategies based on viral vectors have been evaluated in preclinical and…”
Get full text
Journal Article -
14
Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
Published in Cell reports. Medicine (20-04-2021)“…Considerable concerns relating to the duration of protective immunity against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) exist, with evidence…”
Get full text
Journal Article -
15
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys
Published in Science translational medicine (04-05-2011)“…The RV144 vaccine trial in Thailand demonstrated that an HIV vaccine could prevent infection in humans and highlights the importance of understanding…”
Get more information
Journal Article -
16
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost
Published in Journal of virology (01-06-2015)“…An effective human immunodeficiency virus type 1 (HIV-1) vaccine must induce protective antibody responses, as well as CD4(+) and CD8(+) T cell responses, that…”
Get full text
Journal Article -
17
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents
Published in Cell reports. Medicine (21-06-2022)“…Coronavirus disease 2019 (COVID-19) convalescents living in regions with low vaccination rates rely on post-infection immunity for protection against…”
Get full text
Journal Article -
18
Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens
Published in Virology (New York, N.Y.) (05-07-2012)“…Abstract To create an HIV-1 vaccine that generates sufficient breadth of immune recognition to protect against the genetically diverse forms of the circulating…”
Get full text
Journal Article -
19
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates
Published in Journal of virology (15-04-2018)“…A preventive human immunodeficiency virus type 1 (HIV-1) vaccine is an essential part of the strategy to eradicate AIDS. A critical question is whether…”
Get full text
Journal Article -
20
Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes
Published in Virology (New York, N.Y.) (15-01-2015)“…Abstract Simian-human immunodeficiency viruses (SHIVs) that mirror natural transmitted/founder (T/F) viruses in man are needed for evaluation of HIV-1 vaccine…”
Get full text
Journal Article